Pharmaceutical Executive
Mergers have cut the field of companies with real marketing and manufacturing muscle from 25 to five. The 2004 vaccine market will double by 2009.
Andrew Pasternak
Advertisement
Articles by Andrew Pasternak
Advertisement
Latest Updated Articles
Vaccines: Market on the ReboundMay 1st 2006
Advertisement
Advertisement
Trending on PharmExec
1
Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts
2
The Bottlenecks That Slow Manufacturer Response to Increased Demand for Production
3
The Manufacturing Issues That Continue to Contribute to Drug Shortages
4
Bausch + Lomb Appoints Thomas Appio as Interim CEO
5